Foundation Medicine Stock Price, News & Analysis (NASDAQ:FMI)

$67.25 0.90 (1.36 %)
(As of 01/21/2018 03:20 AM ET)
Previous Close$67.25
Today's Range$65.55 - $67.73
52-Week Range$18.00 - $74.30
Volume152,079 shs
Average Volume281,049 shs
Market Capitalization$2.47 billion
P/E Ratio-15.04
Dividend YieldN/A
Beta-0.01

About Foundation Medicine (NASDAQ:FMI)

Foundation Medicine logoFoundation Medicine, Inc. is a molecular information company. The Company sells products that are enabled by its molecular information platform to physicians and biopharmaceutical companies. It is engaged in the business of delivering molecular information about cancer to its customers. Its platform includes various methods and algorithms for analyzing specimens across various types of cancer. Its suite of clinical molecular information products includes FoundationOne, which is used for solid tumors; FoundationOne Heme, which is used for blood-based cancers or hematologic malignancies, including leukemia, lymphoma, myeloma, pediatric cancers and advanced sarcoma; FoundationACT (Assay for Circulating Tumor DNA), which is a blood-based (liquid biopsy) assay that evaluates circulating tumor deoxyribonucleic acid (ctDNA), and FoundationFocus CDxBRCA, which is a companion diagnostic assay to aid in identifying women with ovarian cancer for whom treatment with Rubraca (rucaparib).

Receive FMI News and Ratings via Email

Sign-up to receive the latest news and ratings for FMI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:FMI
CUSIPN/A
Phone+1-617-4182200

Debt

Debt-to-Equity Ratio0.47%
Current Ratio2.24%
Quick Ratio2.03%

Price-To-Earnings

Trailing P/E Ratio-15.0447427293065
Forward P/E Ratio-15.15
P/E GrowthN/A

Sales & Book Value

Annual Sales$116.86 million
Price / Sales20.86
Cash FlowN/A
Price / CashN/A
Book Value$4.70 per share
Price / Book14.31

Profitability

Trailing EPS($4.47)
Net Income$-113,190,000.00
Net Margins-119.69%
Return on Equity-143.18%
Return on Assets-93.58%

Miscellaneous

Employees535
Outstanding Shares36,250,000

Foundation Medicine (NASDAQ:FMI) Frequently Asked Questions

What is Foundation Medicine's stock symbol?

Foundation Medicine trades on the NASDAQ under the ticker symbol "FMI."

How were Foundation Medicine's earnings last quarter?

Foundation Medicine Inc (NASDAQ:FMI) posted its earnings results on Wednesday, November, 1st. The company reported ($0.90) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.06) by $0.16. The company had revenue of $42.66 million for the quarter, compared to analyst estimates of $37.99 million. Foundation Medicine had a negative return on equity of 143.18% and a negative net margin of 119.69%. The firm's quarterly revenue was up 45.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.90) earnings per share. View Foundation Medicine's Earnings History.

When will Foundation Medicine make its next earnings announcement?

Foundation Medicine is scheduled to release their next quarterly earnings announcement on Tuesday, February, 20th 2018. View Earnings Estimates for Foundation Medicine.

Where is Foundation Medicine's stock going? Where will Foundation Medicine's stock price be in 2018?

3 brokers have issued twelve-month price objectives for Foundation Medicine's shares. Their predictions range from $31.00 to $39.00. On average, they anticipate Foundation Medicine's share price to reach $35.00 in the next year. View Analyst Ratings for Foundation Medicine.

Who are some of Foundation Medicine's key competitors?

Who are Foundation Medicine's key executives?

Foundation Medicine's management team includes the folowing people:

  • Michael J. Pellini M.D., Chairman of the Board (Age 52)
  • Steven J. Kafka Ph.D., President, Chief Operating Officer (Age 47)
  • Troy Cox, President, Chief Executive Officer, Director (Age 53)
  • Jason Ryan, Chief Financial Officer, Principal Financial Officer, Principal Accounting officer (Age 42)
  • Robert Hesslein, Senior Vice President, General Counsel (Age 63)
  • Tom Civik, Chief Commercial Officer (Age 48)
  • Vincent Miller M.D., Chief Medical Officer (Age 55)
  • Alexis Borisy, Director (Age 45)
  • Daniel O. Day, Director (Age 52)
  • Michael R. Dougherty, Director (Age 59)

Who owns Foundation Medicine stock?

Foundation Medicine's stock is owned by many different of retail and institutional investors. Top institutional investors include Schwab Charles Investment Management Inc. (0.19%), Ipswich Investment Management Co. Inc. (0.03%) and Creative Planning (0.02%). Company insiders that own Foundation Medicine stock include David Daly, Evan/ Fa Jones, Jason Ryan, Krishna Yeshwant, Michael J Pellini, Robert W Hesslein, Steven J Kafka and Vincent A Miller. View Institutional Ownership Trends for Foundation Medicine.

Who sold Foundation Medicine stock? Who is selling Foundation Medicine stock?

Foundation Medicine's stock was sold by a variety of institutional investors in the last quarter, including Ipswich Investment Management Co. Inc.. Company insiders that have sold Foundation Medicine company stock in the last year include David Daly, Evan/ Fa Jones, Jason Ryan, Krishna Yeshwant, Michael J Pellini, Robert W Hesslein, Steven J Kafka and Vincent A Miller. View Insider Buying and Selling for Foundation Medicine.

Who bought Foundation Medicine stock? Who is buying Foundation Medicine stock?

Foundation Medicine's stock was bought by a variety of institutional investors in the last quarter, including Creative Planning and Schwab Charles Investment Management Inc.. View Insider Buying and Selling for Foundation Medicine.

How do I buy Foundation Medicine stock?

Shares of Foundation Medicine can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Foundation Medicine's stock price today?

One share of Foundation Medicine stock can currently be purchased for approximately $67.25.

How big of a company is Foundation Medicine?

Foundation Medicine has a market capitalization of $2.47 billion and generates $116.86 million in revenue each year. The company earns $-113,190,000.00 in net income (profit) each year or ($4.47) on an earnings per share basis. Foundation Medicine employs 535 workers across the globe.

How can I contact Foundation Medicine?

Foundation Medicine's mailing address is 150 2nd St, CAMBRIDGE, MA 02141-2115, United States. The company can be reached via phone at +1-617-4182200 or via email at [email protected]


MarketBeat Community Rating for Foundation Medicine (FMI)

Community Ranking:  1.4 out of 5 (star)
Outperform Votes:  102 (Vote Outperform)
Underperform Votes:  257 (Vote Underperform)
Total Votes:  359
MarketBeat's community ratings are surveys of what our community members think about Foundation Medicine and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Foundation Medicine (NASDAQ:FMI) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyHold
Consensus Rating Score: 2.672.672.502.40
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $35.00$35.00$35.00$31.67
Price Target Upside: 5.42% upside5.42% upside5.42% upside4.62% downside

Foundation Medicine (NASDAQ:FMI) Consensus Price Target History

Price Target History for Foundation Medicine (NASDAQ:FMI)

Foundation Medicine (NASDAQ:FMI) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/15/2017BTIG ResearchUpgradeNeutral -> Buy$39.00HighView Rating Details
4/3/2017William BlairReiterated RatingBuyLowView Rating Details
3/7/2017Janney Montgomery ScottUpgradeSell -> Neutral$31.00N/AView Rating Details
11/3/2016BenchmarkDowngradeBuy -> HoldN/AView Rating Details
8/3/2016JPMorgan Chase & Co.Reiterated RatingHold$25.00N/AView Rating Details
5/4/2016Leerink SwannReiterated RatingHoldN/AView Rating Details
2/26/2016Goldman Sachs GroupLower Price TargetNeutral$17.00 -> $15.00N/AView Rating Details
(Data available from 1/21/2016 forward)

Earnings

Foundation Medicine (NASDAQ:FMI) Earnings History and Estimates Chart

Earnings by Quarter for Foundation Medicine (NASDAQ:FMI)

Foundation Medicine (NASDAQ FMI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/20/2018($0.99)N/AView Earnings Details
11/1/2017Q3 2017($1.06)($0.90)$37.99 million$42.66 millionViewN/AView Earnings Details
8/1/2017Q2 2017($1.08)($1.24)$34.94 million$35.00 millionViewListenView Earnings Details
5/9/2017Q1 2017($1.02)($1.31)$29.07 million$26.32 millionViewListenView Earnings Details
2/22/2017Q416($0.96)($1.02)$29.23 million$28.80 millionViewListenView Earnings Details
11/2/2016Q316($0.88)($0.90)$28.70 million$29.43 millionViewN/AView Earnings Details
8/2/2016Q216($0.79)($0.84)$26.72 million$28.24 millionViewN/AView Earnings Details
5/3/2016Q116($0.72)($0.50)$25.20 million$30.40 millionViewN/AView Earnings Details
2/23/2016Q415($0.67)($0.55)$25.76 million$26.10 millionViewListenView Earnings Details
11/3/2015Q315($0.56)($0.60)$24.04 million$25.40 millionViewListenView Earnings Details
7/29/2015Q215($0.56)($0.98)$24.44 million$22.50 millionViewListenView Earnings Details
5/11/2015Q115($0.53)($0.59)$21.00 million$19.30 millionViewListenView Earnings Details
2/24/2015Q314($0.53)($0.47)$18.05 million$18.70 millionViewListenView Earnings Details
11/5/2014Q3($0.49)($0.46)$15.60 million$16.40 millionViewN/AView Earnings Details
8/12/2014Q214($0.50)($0.49)$13.39 million$14.50 millionViewN/AView Earnings Details
5/7/2014Q114($0.48)($0.44)$11.33 million$11.45 millionViewN/AView Earnings Details
2/25/2014Q413($0.43)($0.48)$9.01 million$9.66 millionViewN/AView Earnings Details
11/6/2013($0.51)($3.51)$6.92 million$8.20 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Foundation Medicine (NASDAQ:FMI) Earnings Estimates

Current Year EPS Consensus Estimate: $-4.44 EPS
Next Year EPS Consensus Estimate: $-3.81 EPS

Dividends

Dividend History for Foundation Medicine (NASDAQ:FMI)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Foundation Medicine (NASDAQ FMI) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.70%
Institutional Ownership Percentage: 32.68%
Insider Trades by Quarter for Foundation Medicine (NASDAQ:FMI)
Institutional Ownership by Quarter for Foundation Medicine (NASDAQ:FMI)

Foundation Medicine (NASDAQ FMI) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/17/2018Michael J PelliniDirectorSell37,288$64.55$2,406,940.40View SEC Filing  
1/17/2018Vincent A MillerInsiderSell14,755$65.31$963,649.05View SEC Filing  
1/16/2018Jason RyanCFOSell21,035$64.38$1,354,233.30View SEC Filing  
1/16/2018Robert W HessleinSVPSell18,021$64.30$1,158,750.30View SEC Filing  
1/16/2018Steven J KafkaCOOSell4,148$65.71$272,565.08View SEC Filing  
1/2/2018Jason RyanCFOSell2,336$64.00$149,504.00View SEC Filing  
1/2/2018Robert W. HessleinSVPSell1,864$64.00$119,296.00View SEC Filing  
1/2/2018Steven J. KafkaCOOSell157$64.00$10,048.00View SEC Filing  
1/2/2018Vincent A MillerInsiderSell2,349$64.00$150,336.0099,484View SEC Filing  
12/13/2017Evan/ Fa JonesDirectorSell1,400$62.05$86,870.0017,652View SEC Filing  
12/6/2017Evan/ Fa JonesDirectorSell6,500$60.66$394,290.0019,652View SEC Filing  
12/6/2017Steven J KafkaCOOSell5,774$58.57$338,183.1896,761View SEC Filing  
12/5/2017Jason RyanCFOSell21,726$61.26$1,330,934.7655,639View SEC Filing  
12/5/2017Vincent A MillerInsiderSell20,000$61.17$1,223,400.0099,984View SEC Filing  
11/2/2017Jason RyanCFOSell9,731$50.00$486,550.0052,601View SEC Filing  
10/13/2017Steven J KafkaCOOSell3,361$44.62$149,967.82View SEC Filing  
10/12/2017Jason RyanCFOSell1,152$45.05$51,897.60View SEC Filing  
10/2/2017Jason RyanCFOSell3,154$38.80$122,375.20View SEC Filing  
10/2/2017Michael J PelliniDirectorSell4,349$38.80$168,741.20View SEC Filing  
10/2/2017Robert W HessleinSVPSell2,165$38.80$84,002.00View SEC Filing  
10/2/2017Steven J KafkaCOOSell3,201$38.80$124,198.80View SEC Filing  
10/2/2017Vincent A MillerInsiderSell2,944$38.80$114,227.20View SEC Filing  
8/9/2017David DalyInsiderSell46,872$39.50$1,851,444.00163,133View SEC Filing  
8/9/2017Michael J PelliniDirectorSell30,000$39.52$1,185,600.00275,077View SEC Filing  
8/8/2017Krishna YeshwantDirectorSell4,800$40.01$192,048.005,786View SEC Filing  
8/4/2017Krishna YeshwantDirectorSell18,072$36.85$665,953.205,786View SEC Filing  
7/14/2017Steven J KafkaCOOSell11,781$39.15$461,226.1597,549View SEC Filing  
7/13/2017Jason RyanCFOSell5,084$39.77$202,190.6866,638View SEC Filing  
7/6/2017David DalyInsiderSell6,316$38.84$245,313.44View SEC Filing  
7/6/2017Jason RyanCFOSell6,683$38.84$259,567.72View SEC Filing  
7/6/2017Michael J. PelliniDirectorSell15,856$38.84$615,847.04View SEC Filing  
7/6/2017Robert W. HessleinSVPSell5,070$38.84$196,918.80View SEC Filing  
7/6/2017Steven J KafkaCOOSell19,708$38.93$767,232.44116,728View SEC Filing  
7/5/2017Steven J KafkaCOOSell12,310$38.98$479,843.80116,728View SEC Filing  
6/2/2017Jason RyanCFOSell5,573$40.00$222,920.0078,405View SEC Filing  
6/1/2017David DalyInsiderSell555$38.30$21,256.50View SEC Filing  
4/18/2017Jason RyanCFOSell503$34.55$17,378.6551,244View SEC Filing  
4/18/2017Steven J KafkaCOOSell4,405$34.55$152,192.75129,038View SEC Filing  
4/3/2017David DalyInsiderSell2,070$31.96$66,157.20View SEC Filing  
4/3/2017Michael J. PelliniDirectorSell1,700$31.96$54,332.00View SEC Filing  
4/3/2017Robert W. HessleinSVPSell1,233$31.96$39,406.68View SEC Filing  
4/3/2017Steven J. KafkaCOOSell2,157$31.96$68,937.72View SEC Filing  
3/16/2017Jason RyanCFOSell12,500$31.68$396,000.0056,230View SEC Filing  
3/16/2017Robert W HessleinSVPSell6,231$31.67$197,335.77104,305View SEC Filing  
3/8/2017Michael J PelliniDirectorSell40,000$34.30$1,372,000.00353,144View SEC Filing  
2/8/2017Steven J KafkaCOOSell10,415$23.24$242,044.60146,015View SEC Filing  
1/13/2017Jason RyanCFOSell1,777$19.00$33,763.0052,980View SEC Filing  
1/4/2017David DalyInsiderSell5,097$17.91$91,287.27View SEC Filing  
1/4/2017Jason RyanCFOSell4,665$17.74$82,757.10View SEC Filing  
1/4/2017Michael J. PelliniCEOSell14,637$17.67$258,635.79View SEC Filing  
1/4/2017Robert W. HessleinSVPSell4,682$17.74$83,058.68View SEC Filing  
1/4/2017Steven J. KafkaCOOSell8,390$17.72$148,670.80View SEC Filing  
12/1/2016David DalyInsiderSell564$19.95$11,251.80View SEC Filing  
11/22/2016Steven J KafkaCOOSell6,273$23.01$144,341.73103,009View SEC Filing  
10/20/2016Jason RyanCFOSell506$22.45$11,359.7059,422View SEC Filing  
10/20/2016Steven J KafkaCOOSell4,427$23.00$101,821.00101,550View SEC Filing  
10/4/2016David DalyInsiderSell2,045$23.65$48,364.25View SEC Filing  
10/4/2016Michael J. PelliniCEOSell2,629$23.65$62,175.85View SEC Filing  
10/4/2016Robert W. HessleinSVPSell1,220$23.65$28,853.00View SEC Filing  
10/4/2016Steven J. KafkaCOOSell2,135$23.62$50,428.70View SEC Filing  
9/20/2016Steven J KafkaCOOSell9,469$23.70$224,415.30108,112View SEC Filing  
8/19/2016Jason RyanCFOSell13,863$23.92$331,602.9661,148View SEC Filing  
7/5/2016David DalyInsiderSell5,008$17.76$88,942.08View SEC Filing  
7/5/2016Jason RyanCFOSell4,687$17.63$82,631.81View SEC Filing  
7/5/2016Michael J. PelliniCEOSell10,160$17.63$179,120.80View SEC Filing  
7/5/2016Robert W. HessleinSVPSell4,705$17.62$82,902.10View SEC Filing  
7/5/2016Steven J. KafkaCOOSell6,495$17.67$114,766.65View SEC Filing  
6/3/2016David DalyInsiderSell472$21.66$10,223.52114,458View SEC Filing  
4/1/2016Steven J KafkaCOOSell124$18.08$2,241.9241,226View SEC Filing  
4/1/2016Vincent A MillerInsiderSell356$18.08$6,436.4878,482View SEC Filing  
12/1/2015David DalyInsiderSell2,559$16.78$42,940.0245,631View SEC Filing  
11/13/2015Michael J PelliniCEOBuy9,100$16.43$149,513.00174,025View SEC Filing  
6/15/2015Krishna YeshwantDirectorSell183,860$32.98$6,063,702.80View SEC Filing  
4/7/2015Alexis BorisyDirectorSell234,542$50.00$11,727,100.00View SEC Filing  
4/7/2015Roche Holdings IncInsiderBuy15,604,288$50.00$780,214,400.00View SEC Filing  
4/7/2015Rock Ventures Lp ThirdMajor ShareholderSell3,976,278$50.00$198,813,900.00View SEC Filing  
3/5/2015Michael J PelliniCEOSell153,300$47.24$7,241,892.00View SEC Filing  
1/15/2015Steven J KafkaCOOSell15,000$48.38$725,700.00View SEC Filing  
1/12/2015Michael J PelliniCEOSell22,500$51.07$1,149,075.00View SEC Filing  
1/12/2015Robert W HessleinSVPSell7,000$52.11$364,770.00View SEC Filing  
1/12/2015Steven J KafkaCOOSell8,000$51.83$414,640.00View SEC Filing  
1/12/2015Vincent A MillerInsiderSell2,000$53.03$106,060.00View SEC Filing  
1/8/2015Robert W HessleinSVPSell4,000$23.03$92,120.00View SEC Filing  
12/29/2014Michael J PelliniCEOSell12,500$23.91$298,875.00View SEC Filing  
11/17/2014Jason RyanSVPSell3,541$24.90$88,170.90View SEC Filing  
11/14/2014Michael J PelliniCEOSell12,500$24.91$311,375.00View SEC Filing  
10/27/2014Jason RyanSVPSell2,360$25.00$59,000.00View SEC Filing  
10/27/2014Steven J KafkaCOOSell10,000$25.31$253,100.00View SEC Filing  
9/15/2014Jason RyanSVPSell2,361$21.92$51,753.12View SEC Filing  
8/18/2014Michael J PelliniCEOSell12,500$25.29$316,125.00View SEC Filing  
7/22/2014Steven J KafkaCOOSell10,000$27.14$271,400.00View SEC Filing  
7/15/2014Jason RyanSVPSell3,541$27.22$96,386.02View SEC Filing  
7/15/2014Vincent A MillerInsiderSell15,000$27.25$408,750.00View SEC Filing  
7/8/2014Robert W HessleinSVPSell4,000$27.22$108,880.00View SEC Filing  
7/2/2014Michael J PelliniCEOSell15,000$27.42$411,300.00View SEC Filing  
6/26/2014Jason RyanSVPSell1,180$25.00$29,500.00View SEC Filing  
6/26/2014Steven J KafkaCOOSell5,000$25.19$125,950.00View SEC Filing  
6/19/2014Steven J KafkaCOOSell5,000$24.46$122,300.00View SEC Filing  
6/16/2014Jason RyanSVPSell2,361$22.61$53,382.21View SEC Filing  
6/13/2014Krishna YeshwantDirectorSell1,300,000$22.40$29,120,000.00View SEC Filing  
6/5/2014Jason RyanSVPSell10,000$24.06$240,600.00View SEC Filing  
6/5/2014Steven J KafkaCOOSell4,500$24.19$108,855.00View SEC Filing  
5/6/2014Vincent MillerInsiderSell3,000$30.00$90,000.00117,000View SEC Filing  
4/16/2014Jason RyanSVPSell3,541$26.36$93,340.76View SEC Filing  
4/16/2014Vincent MillerInsiderSell30,000$26.86$805,800.00120,000View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Foundation Medicine (NASDAQ FMI) News Headlines

Source:
DateHeadline
Steven J. Kafka Sells 4,148 Shares of Foundation Medicine Inc (FMI) StockSteven J. Kafka Sells 4,148 Shares of Foundation Medicine Inc (FMI) Stock
www.americanbankingnews.com - January 18 at 7:34 PM
Foundation Medicine Inc (FMI) Insider Sells $963,649.05 in StockFoundation Medicine Inc (FMI) Insider Sells $963,649.05 in Stock
www.americanbankingnews.com - January 18 at 7:00 PM
Foundation Medicine Inc (FMI) SVP Sells $1,158,750.30 in StockFoundation Medicine Inc (FMI) SVP Sells $1,158,750.30 in Stock
www.americanbankingnews.com - January 18 at 7:00 PM
Insider Selling: Foundation Medicine Inc (FMI) CFO Sells 21,035 Shares of StockInsider Selling: Foundation Medicine Inc (FMI) CFO Sells 21,035 Shares of Stock
www.americanbankingnews.com - January 18 at 7:00 PM
Insider Selling: Foundation Medicine Inc (FMI) Director Sells 37,288 Shares of StockInsider Selling: Foundation Medicine Inc (FMI) Director Sells 37,288 Shares of Stock
www.americanbankingnews.com - January 18 at 6:34 PM
Foundation Medicine and Pfizer Announce Broad Partnership to Develop Companion Diagnostics for Pfizers Oncology ... - Business Wire (press release)Foundation Medicine and Pfizer Announce Broad Partnership to Develop Companion Diagnostics for Pfizer's Oncology ... - Business Wire (press release)
www.businesswire.com - January 18 at 4:57 PM
Foundation Medicine, Pfizer Enter Into Broad Tie-up For Companion DiagnosticsFoundation Medicine, Pfizer Enter Into Broad Tie-up For Companion Diagnostics
www.nasdaq.com - January 16 at 9:31 AM
-$1.00 Earnings Per Share Expected for Foundation Medicine Inc (FMI) This Quarter-$1.00 Earnings Per Share Expected for Foundation Medicine Inc (FMI) This Quarter
www.americanbankingnews.com - January 15 at 5:38 AM
Foundation Medicine Inc (FMI) Given Average Rating of "Hold" by AnalystsFoundation Medicine Inc (FMI) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - January 10 at 1:44 AM
Insider Selling: Foundation Medicine Inc (FMI) COO Sells 157 Shares of StockInsider Selling: Foundation Medicine Inc (FMI) COO Sells 157 Shares of Stock
www.americanbankingnews.com - January 3 at 7:52 PM
Foundation Medicine Inc (FMI) SVP Robert W. Hesslein Sells 1,864 SharesFoundation Medicine Inc (FMI) SVP Robert W. Hesslein Sells 1,864 Shares
www.americanbankingnews.com - January 3 at 7:28 PM
Vincent A. Miller Sells 2,349 Shares of Foundation Medicine Inc (FMI) StockVincent A. Miller Sells 2,349 Shares of Foundation Medicine Inc (FMI) Stock
www.americanbankingnews.com - January 3 at 7:28 PM
Foundation Medicine Inc (FMI) CFO Jason Ryan Sells 2,336 SharesFoundation Medicine Inc (FMI) CFO Jason Ryan Sells 2,336 Shares
www.americanbankingnews.com - January 3 at 7:28 PM
What does Foundation Medicine Inc’s (NASDAQ:FMI) Balance Sheet Tell Us Abouts Its Future?What does Foundation Medicine Inc’s (NASDAQ:FMI) Balance Sheet Tell Us Abouts Its Future?
finance.yahoo.com - January 3 at 5:25 PM
Foundation Medicine to Present at the 36th Annual J.P. Morgan Healthcare ConferenceFoundation Medicine to Present at the 36th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 3 at 5:25 PM
Zacks: Analysts Expect Foundation Medicine Inc (FMI) to Announce -$1.00 EPSZacks: Analysts Expect Foundation Medicine Inc (FMI) to Announce -$1.00 EPS
www.americanbankingnews.com - December 29 at 9:30 AM
Foundation Medicine (FMI) Upgraded by BidaskClub to "Buy"Foundation Medicine (FMI) Upgraded by BidaskClub to "Buy"
www.americanbankingnews.com - December 28 at 4:56 PM
Foundation Medicine (FMI) Downgraded to Hold at BidaskClubFoundation Medicine (FMI) Downgraded to Hold at BidaskClub
www.americanbankingnews.com - December 24 at 8:15 AM
Foundation Medicine Inc (FMI) Receives Average Rating of "Buy" from BrokeragesFoundation Medicine Inc (FMI) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - December 16 at 1:52 AM
Insider Selling: Foundation Medicine Inc (FMI) Director Sells 1,400 Shares of StockInsider Selling: Foundation Medicine Inc (FMI) Director Sells 1,400 Shares of Stock
www.americanbankingnews.com - December 15 at 6:32 PM
ETFs with exposure to Foundation Medicine, Inc. : December 14, 2017ETFs with exposure to Foundation Medicine, Inc. : December 14, 2017
finance.yahoo.com - December 14 at 5:54 PM
Zacks: Brokerages Expect Foundation Medicine Inc (FMI) Will Post Quarterly Sales of $39.56 MillionZacks: Brokerages Expect Foundation Medicine Inc (FMI) Will Post Quarterly Sales of $39.56 Million
www.americanbankingnews.com - December 14 at 4:16 PM
Foundation Medicine (FMI) Upgraded to "Buy" at BidaskClubFoundation Medicine (FMI) Upgraded to "Buy" at BidaskClub
www.americanbankingnews.com - December 12 at 10:48 PM
Foundation Medicine Inc (FMI) Expected to Post Earnings of -$1.00 Per ShareFoundation Medicine Inc (FMI) Expected to Post Earnings of -$1.00 Per Share
www.americanbankingnews.com - December 12 at 5:06 AM
Foundation Medicine CEO talks the future of cancer treatm...Foundation Medicine CEO talks the future of cancer treatm...
finance.yahoo.com - December 11 at 5:34 PM
Foundation Medicine Inc (FMI) COO Sells $338,183.18 in StockFoundation Medicine Inc (FMI) COO Sells $338,183.18 in Stock
www.americanbankingnews.com - December 7 at 5:56 PM
Foundation Medicine Inc (FMI) Director Evan/ Fa Jones Sells 6,500 SharesFoundation Medicine Inc (FMI) Director Evan/ Fa Jones Sells 6,500 Shares
www.americanbankingnews.com - December 7 at 5:56 PM
Foundation Medicine Inc (FMI) CFO Jason Ryan Sells 21,726 SharesFoundation Medicine Inc (FMI) CFO Jason Ryan Sells 21,726 Shares
www.americanbankingnews.com - December 7 at 5:26 PM
Foundation Medicine Inc (FMI) Insider Vincent A. Miller Sells 20,000 SharesFoundation Medicine Inc (FMI) Insider Vincent A. Miller Sells 20,000 Shares
www.americanbankingnews.com - December 7 at 5:26 PM
Foundation Medicine (FMI) Upgraded to Buy at Zacks Investment ResearchFoundation Medicine (FMI) Upgraded to Buy at Zacks Investment Research
www.americanbankingnews.com - December 6 at 9:58 PM
Top Stock Gainers & News Inspiring Rally - AMWD, SFIX, FMI, AMBA, CVNA - NasdaqTop Stock Gainers & News Inspiring Rally - AMWD, SFIX, FMI, AMBA, CVNA - Nasdaq
www.nasdaq.com - December 4 at 5:21 PM
Traders Purchase High Volume of Put Options on Foundation Medicine (FMI)Traders Purchase High Volume of Put Options on Foundation Medicine (FMI)
www.americanbankingnews.com - December 4 at 2:26 AM
Charting the Market: Foundation Medicine’s Test Flags 324 Cancer GenesCharting the Market: Foundation Medicine’s Test Flags 324 Cancer Genes
www.barrons.com - December 2 at 9:52 AM
Charting the Market: Foundation Medicines Test Flags 324 Cancer GenesCharting the Market: Foundation Medicine's Test Flags 324 Cancer Genes
finance.yahoo.com - December 2 at 9:52 AM
Bloomberg Markets: Flynn Fingers Trump Team - BloombergBloomberg Markets: Flynn Fingers Trump Team - Bloomberg
www.bloomberg.com - December 1 at 4:49 PM
Foundation Medicine gets nod from FDA and Medicare for cancer testFoundation Medicine gets nod from FDA and Medicare for cancer test
finance.yahoo.com - November 30 at 5:18 PM
ETFs with exposure to Foundation Medicine, Inc. : November 29, 2017ETFs with exposure to Foundation Medicine, Inc. : November 29, 2017
finance.yahoo.com - November 29 at 5:42 PM
 Analysts Anticipate Foundation Medicine, Inc. (FMI) Will Post Quarterly Sales of $38.57 Million Analysts Anticipate Foundation Medicine, Inc. (FMI) Will Post Quarterly Sales of $38.57 Million
www.americanbankingnews.com - November 26 at 12:10 PM
 Analysts Expect Foundation Medicine, Inc. (FMI) Will Post Earnings of -$0.98 Per Share Analysts Expect Foundation Medicine, Inc. (FMI) Will Post Earnings of -$0.98 Per Share
www.americanbankingnews.com - November 24 at 8:24 AM
Foundation Medicine, Inc. (FMI) Receives Consensus Recommendation of "Hold" from BrokeragesFoundation Medicine, Inc. (FMI) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - November 21 at 1:44 AM
Reviewing Foundation Medicine (FMI) & Its RivalsReviewing Foundation Medicine (FMI) & Its Rivals
www.americanbankingnews.com - November 17 at 7:22 AM
Foundation Medicine, Inc. (FMI) Expected to Announce Quarterly Sales of $38.57 MillionFoundation Medicine, Inc. (FMI) Expected to Announce Quarterly Sales of $38.57 Million
www.americanbankingnews.com - November 15 at 1:18 PM
Brokerages Expect Foundation Medicine, Inc. (FMI) to Post ($0.98) EPSBrokerages Expect Foundation Medicine, Inc. (FMI) to Post ($0.98) EPS
www.americanbankingnews.com - November 13 at 11:54 AM
Commit To Purchase Foundation Medicine At $40, Earn 12.7% Annualized Using OptionsCommit To Purchase Foundation Medicine At $40, Earn 12.7% Annualized Using Options
www.nasdaq.com - November 9 at 3:43 AM
Options Traders Expect Huge Moves in Foundation Medicine (FMI) StockOptions Traders Expect Huge Moves in Foundation Medicine (FMI) Stock
finance.yahoo.com - November 8 at 6:59 AM
Zacks Investment Research Downgrades Foundation Medicine, Inc. (FMI) to HoldZacks Investment Research Downgrades Foundation Medicine, Inc. (FMI) to Hold
www.americanbankingnews.com - November 7 at 11:10 PM
 Brokerages Anticipate Foundation Medicine, Inc. (FMI) Will Announce Quarterly Sales of $42.20 Million Brokerages Anticipate Foundation Medicine, Inc. (FMI) Will Announce Quarterly Sales of $42.20 Million
www.americanbankingnews.com - November 7 at 4:36 AM
Foundation Medicine, Inc. (FMI) Upgraded by Zacks Investment Research to "Buy"Foundation Medicine, Inc. (FMI) Upgraded by Zacks Investment Research to "Buy"
www.americanbankingnews.com - November 6 at 11:36 PM
ETFs with exposure to Foundation Medicine, Inc. : November 6, 2017ETFs with exposure to Foundation Medicine, Inc. : November 6, 2017
finance.yahoo.com - November 6 at 10:48 PM
Foundation Medicine, Inc. (FMI) CFO Jason Ryan Sells 9,731 SharesFoundation Medicine, Inc. (FMI) CFO Jason Ryan Sells 9,731 Shares
www.americanbankingnews.com - November 6 at 6:58 PM

SEC Filings

Foundation Medicine (NASDAQ:FMI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Foundation Medicine (NASDAQ:FMI) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Foundation Medicine (NASDAQ FMI) Stock Chart for Sunday, January, 21, 2018

Loading chart…

This page was last updated on 1/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.